All Set For EU Approval: First Biosimilar Humalog And Three More Rituximabs From Celltrion

 
• By Ian Schofield and Maureen Kenny

The European Medicines Agency has given the thumbs-up to Insulin lispro Sanofi, the first biosimilar version of Lilly’s diabetes drug Humalog. It has also green-lighted three more biosimilar rituximab products from Celltrion, which already has EU approval for one version of the originator product, Roche’s MabThera.

Diabetes
The EU's CHMP has OKd the first biosimilar version of Lilly's antidiabetic Humalog

More from Biosimilars

More from Biosimilars & Generics